Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) is dated March 20, 2013. The report discloses the material terms of a separation agreement with Jeffrey B. Paulsen, former Group President of Global Businesses, effective March 20, 2013.
Key Financial Metrics
The filing does not provide general financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on the specific severance costs associated with Mr. Paulsen's departure:
- Lump Sum Payment: $243,750 (equal to six months of base salary).
- Health Insurance: $8,100 (COBRA coverage for six months).
- Outplacement Services: Up to $25,000.
- Equity: Accelerated vesting of time-based conditions on certain stock options and restricted stock units; vested options exercisable until June 20, 2013.
Material Changes
The primary material change is the execution of a separation agreement for a Named Executive Officer. The terms were not finalized in the prior report filed on March 15, 2013, and were agreed upon on March 20, 2013.
Outlook, Risks, and Contingencies
Contingencies and Clawbacks: All payments and equity benefits are subject to forfeiture, clawback, and full repayment if Mr. Paulsen violates the separation agreement, general release, or confidentiality, non-competition, and non-solicitation agreements.
Revocation Period: The separation agreement and general release remain subject to revocation by Mr. Paulsen through March 27, 2013.
Investor Verification Checklist
- Confirm whether the separation agreement was revoked by Mr. Paulsen before the March 27, 2013 deadline.
- Verify the actual amount of outplacement services utilized (capped at $25,000).
- Monitor future filings for any clawback actions or disputes regarding the separation terms.
- Check subsequent 10-Q or 10-K filings to see how these severance costs were classified in the financial statements.